Cullinan Therapeutics Inc Major Shareholders & Ownership History
| Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
|---|---|---|---|---|---|
| BIOIMPACT CAPITAL LLC | 08/14/2026 | 9.73 M | $177.21 M | 27.24% | 16.44% |
| LYNX1 CAPITAL MANAGEMENT LP | 08/13/2026 | 8.96 M | $163.23 M | 0.00% | 15.14% |
| BVF INC/IL | 08/14/2026 | 5.75 M | $104.72 M | 0.00% | 9.71% |
| BLACKROCK, INC. | 08/07/2026 | 5.23 M | $95.29 M | 17.59% | 8.84% |
| PRICE T ROWE ASSOCIATES INC /MD/ | 08/14/2026 | 3.83 M | $69.67 M | 88.50% | 6.46% |
| STATE STREET CORP | 08/07/2026 | 3.67 M | $66.81 M | 44.20% | 6.20% |
| KYNAM CAPITAL MANAGEMENT, LP | 08/14/2026 | 3.11 M | $56.71 M | 0.00% | 5.26% |
| VANGUARD CAPITAL MANAGEMENT LLC | 08/13/2026 | 2.61 M | $47.60 M | 5.28% | 4.42% |
| RTW INVESTMENTS, LP | 08/14/2026 | 2.36 M | $43.05 M | 38.59% | 3.99% |
| SIREN, L.L.C. | 08/13/2026 | 1.89 M | $34.48 M | 58.66% | 3.20% |
| GEODE CAPITAL MANAGEMENT, LLC | 08/12/2026 | 1.55 M | $28.18 M | 13.09% | 2.61% |
| BLUE OWL CAPITAL HOLDINGS LP | 08/11/2026 | 1.54 M | $28.04 M | -19.37% | 2.60% |
| VR ADVISER, LLC | 08/14/2026 | 1.38 M | $25.13 M | 0.00% | 2.33% |
| BOOTHBAY FUND MANAGEMENT, LLC | 08/14/2026 | 1.08 M | $19.71 M | -2.71% | 1.83% |
| DIMENSIONAL FUND ADVISORS LP | 08/11/2026 | 1.05 M | $19.06 M | 15.53% | 1.77% |
| GOLDMAN SACHS GROUP INC | 08/14/2026 | 1.00 M | $18.24 M | 119.91% | 1.69% |
| AFFINITY ASSET ADVISORS, LLC | 08/13/2026 | 875.76 K | $15.95 M | 12.10% | 1.48% |
| VANGUARD PORTFOLIO MANAGEMENT LLC | 08/13/2026 | 738.74 K | $13.45 M | 33.70% | 1.25% |
| BOONE CAPITAL MANAGEMENT LLC | 08/14/2026 | 704.44 K | $12.83 M | 100.00% | 1.19% |
| ELMIND CAPITAL, LP | 08/14/2026 | 690.00 K | $12.56 M | 30.19% | 1.17% |
| MORGAN STANLEY | 08/13/2026 | 629.04 K | $11.45 M | 6.71% | 1.06% |
| TWIN FOCUS CAPITAL PARTNERS, LLC | 07/28/2026 | 595.49 K | $10.84 M | 0.00% | 1.01% |
| AQR CAPITAL MANAGEMENT LLC | 08/14/2026 | 581.34 K | $10.59 M | 61.09% | 0.98% |
| NORTHERN TRUST CORP | 08/13/2026 | 571.08 K | $10.40 M | 27.12% | 0.96% |
| BANK OF AMERICA CORP /DE/ | 08/14/2026 | 510.33 K | $9.29 M | -1.24% | 0.86% |
| NUVEEN, LLC | 08/11/2026 | 471.95 K | $8.59 M | -41.42% | 0.80% |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 08/14/2026 | 464.03 K | $8.45 M | 7.19% | 0.78% |
| SIXTH STREET PARTNERS MANAGEMENT COMPANY, L.P. | 08/14/2026 | 464.03 K | $8.45 M | 100.00% | 0.78% |
| PERCEPTIVE ADVISORS LLC | 08/14/2026 | 426.48 K | $7.77 M | 100.00% | 0.72% |
| TCG CROSSOVER MANAGEMENT, LLC | 08/14/2026 | 406.79 K | $7.41 M | 0.00% | 0.69% |
| CITADEL ADVISORS LLC | 08/14/2026 | 397.48 K | $7.24 M | 57.25% | 0.67% |
| DEUTSCHE BANK AG\ | 08/07/2026 | 382.84 K | $6.97 M | 4.06% | 0.65% |
| VANGUARD FIDUCIARY TRUST CO | 08/13/2026 | 363.14 K | $6.61 M | 5.92% | 0.61% |
| MILLENNIUM MANAGEMENT LLC | 08/14/2026 | 346.23 K | $6.30 M | -0.10% | 0.58% |
| RENAISSANCE TECHNOLOGIES LLC | 08/13/2026 | 326.81 K | $5.95 M | 0.83% | 0.55% |
| GREAT POINT PARTNERS LLC | 08/14/2026 | 300.00 K | $5.46 M | 0.00% | 0.51% |
| CONNOR, CLARK & LUNN INVESTMENT MANAGEMENT LTD. | 08/13/2026 | 292.50 K | $5.33 M | 1.17% | 0.49% |
| JPMORGAN CHASE & CO | 08/12/2026 | 282.63 K | $5.21 M | -4.91% | 0.48% |
| TWO SIGMA INVESTMENTS, LP | 08/14/2026 | 272.58 K | $4.96 M | -47.79% | 0.46% |
| BLEICHROEDER LP | 08/13/2026 | 250.00 K | $4.55 M | 150.00% | 0.42% |
| UBS GROUP AG | 08/13/2026 | 248.63 K | $4.53 M | 22.85% | 0.42% |
| FMR LLC | 08/13/2026 | 240.12 K | $4.37 M | 3,220.17% | 0.41% |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | 08/14/2026 | 238.00 K | $4.33 M | 100.00% | 0.40% |
| SUSQUEHANNA PORTFOLIO STRATEGIES, LLC | 08/14/2026 | 233.84 K | $4.26 M | 0.00% | 0.40% |
| PFM HEALTH SCIENCES, LP | 08/14/2026 | 192.44 K | $3.50 M | -15.38% | 0.33% |
| MOORE CAPITAL MANAGEMENT, LP | 08/14/2026 | 189.95 K | $3.46 M | 79.26% | 0.32% |
| BANK OF NEW YORK MELLON CORP | 08/06/2026 | 171.03 K | $3.11 M | 19.01% | 0.29% |
| SQUAREPOINT OPS LLC | 08/14/2026 | 168.12 K | $3.06 M | 100.00% | 0.28% |
| PRUDENTIAL FINANCIAL INC | 08/12/2026 | 167.56 K | $3.05 M | 12.12% | 0.28% |
| WELLINGTON MANAGEMENT GROUP LLP | 08/14/2026 | 164.72 K | $3.00 M | 10.09% | 0.28% |
Explore Related Stocks for Market Trends
Explore our related stocks for the latest market trends and stock news to stay informed and make better decisions.
Cullinan Therapeutics Inc institutional Ownership - FAQ's
During the previous two years, 230 institutional investors and hedge funds held shares of Cullinan Therapeutics Inc. The most heavily invested institutionals were:
BioImpact Capital LLC: 9.73 M
Lynx1 Capital Management LP: 8.96 M
BVF INC/IL: 5.75 M
BlackRock, Inc.: 5.23 M
PRICE T ROWE ASSOCIATES INC /MD/: 3.83 M
STATE STREET CORP: 3.67 M
121.70% of Cullinan Therapeutics Inc stock is owned by institutional investors.
Institutional investors have bought a total of 85.26 M shares in the last 24 months. This purchase volume represents approximately $1.31 B in transactions.